Why Invest in Med-X Before the Planned Nasdaq Listing? ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏




 

_You are receiving this email because you are subscribed to MORNING
WATCHLIST FROM BEHIND THE MARKETS. If you no longer wish to receive
these partner emails, please unsubscribe
[[link removed]]
here. This message is from Med-x Inc._

 

-------------------------

MED-X IS PREPARING FOR A POSSIBLE NASDAQ LISTING (TICKER: MXRX). BUT
THE REAL OPPORTUNITY IS NOW – BEFORE GLOBAL VALIDATION CHANGES
EVERYTHING.

In independent lab studies, Med-X's all-natural pesticides have
outperformed chemical brands in certain use cases, delivering powerful
results without the toxic tradeoffs associated with traditional pest
control.

Now, Med-X is pursuing a potential milestone that could redefine the
industry: becoming THE FIRST BOTANICAL PESTICIDE EVER PRE-QUALIFIED BY
THE WORLD HEALTH ORGANIZATION.

The global biopesticide market is projected to grow nearly 3X BY 2030,
expanding from $5.8 billion to $17.6 billion as governments move away
from synthetic chemicals. A WHO pre-qualification would position
Nature-Cide as a globally recognized solution for public health,
agriculture, and mosquito-borne disease control – opening doors that
most pesticide companies can't access.

Nature-Cide's plant-based formulation prioritizes safety while
delivering industrial-grade performance, challenging long-held
assumptions about what botanical solutions can achieve on a global
scale.

NASDAQ TICKER: MXRX RESERVED!
The Real Opportunity to Become a Shareholder Is Now!
[[link removed]]

[Artistic camera angel on Wall St with the words Med-X | BECOME A
SHAREHOLDER BEFORE OUR PLANNED NASDAQ LISTING | Reserved Nasdaq
Ticker: MXRX | Learn More]
[[link removed]]

Med-X has earned national and international recognition for providing
effective alternatives to conventional pesticides across residential,
commercial, agricultural, and public-health sectors. Proudly
manufactured in the USA, Nature-Cide reflects a commitment to
scalable, sustainable innovation.

Already sold through eCommerce giants AMAZON, WALMART, AND KROGER, and
expanding into 41 INTERNATIONAL MARKETS, Med-X is positioning itself
for its next major chapter.

SIMPLER. SAFER. MORE EFFECTIVE PESTICIDES.

Become a Med-X shareholder at $4 per share before their NASDAQ plans
unfold.
[[link removed]]

-------------------------

Disclosures

This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com
[[link removed]]

We are issuing this disclosure in compliance with Section 17(b) of the
Securities Act, which requires us to disclose any compensation
received or expected to be received in cash or in kind in connection
with the purchase or sale of any security.

We would like to inform you that this is a paid advertisement for
Med-X's Regulation A+ Offering offering and we have received or expect
to receive compensation in connection with the disbursing this
communication for Med-X . The compensation could consist of $1,000 or
more and was received/will be received from Investing Media Solutions.

This communication should not be considered as an endorsement of Med-X
and we are not responsible for any errors or omissions in any
information provided about by or about Med-X.

We encourage you to conduct your own due diligence and research before
making any investment decisions. You should also consult with a
financial advisor before making any investment decisions.

This disclosure is made as of 01/21/2026.

Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431

Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the
Markets. For more information about our privacy practices, please
review our Privacy Policy
[[link removed]]
or our Legal Notices.
[[link removed]]


Behind the Markets
[[link removed]]

_You are receiving this email because you are subscribed to Morning
Watchlist from Behind the Markets. If you no longer wish to receive
these partner emails, please unsubscribe here
[[link removed]]._


TODAY'S BONUS CONTENT: “Big, Beautiful Bill” = the next bull
market? [[link removed]]